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Abstract
Background: We assessed the integration of PMTCT services during the postpartum period including early infant diagnosis
of HIV (EID) and adult and pediatric antiretroviral therapy (ART) in maternal and child health (MCH) facilities in Zimbabwe
Methods and Findings: From August to December 2012 we conducted a cross-sectional survey of a nationally
representative sample of 151 MCH facilities. A questionnaire was used to survey each site about staff training, dried blood
spot sample (DBS) collection, turnaround time (TAT) for test results, PMTCT services, and HIV care and treatment linkages for
HIV-infected mothers and children and HIV-exposed infants. Descriptive analyses were used. Of the facilities surveyed, all
facilities were trained on DBS collection and 92% responded. Approximately, 99% of responding facilities reported
providing DBS collection and a basic HIV-exposed infant service package including EID, extended nevirapine prophylaxis,
and use of cotrimoxazole. DBS collection was integrated with immunisations at 83% of facilities, CD4 testing with point-of-
care machines was available at 37% of facilities, and ART for both mothers and children was provided at 27% of facilities.
More than 80% of facilities reported that DBS test results take .4 weeks to return; TAT did not have a direct association with
any specific type of transport, distance to the lab, or intermediate stops for data to travel.
Conclusions: Zimbabwe has successfully scaled up and integrated the national EID and PMTCT programs into the existing
MCH setting. The long TAT of infant DBS test results and the lack of integrated ART programs in the MCH setting could
reduce effectiveness of the national PMTCT and ART programs. Addressing these important gaps will support successful
implementation of the 2014 Zimbabwe’s PMTCT guidelines under which all HIV-infected pregnant and breastfeeding
women will be offered life-long ART and decentralized ART care.
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Introduction
HIV infections continue to be a source of significant mortality in
the pediatric population. As of 2012, approximately 3.3 million
children younger than 15 years were living with HIV worldwide,
and there were 260,000 new infections in children [1]. Mortality is
high among HIV-infected infants in their first year of life;
approximately 30% of HIV-positive children do not survive to
their first birthday, and half die before the age of two years [2].
Mother-to-child transmission of HIV (MTCT) is by far the most
common source of pediatric HIV infection, responsible for greater
than 90% of new HIV infections among infants [3]. In an effort to
reduce mortality of children less than five years of age, the World
Health Organization (WHO), United Nations and AIDS (UN-
AIDS) and United Nations Children’s Fund (UNICEF) with
supports from other international health partners, have called for
eliminating HIV infections in children and keeping their mothers
alive. Prevention of mother-to-child-transmission (PMTCT) inter-
ventions can reduce MTCT to less than 5% [4].
In Zimbabwe, a country that saw a decline in HIV prevalence
from 22.8% to 14.7% between 2002 and 2012 [5], HIV and
acquired immunodeficiency syndrome (AIDS) remain the single
leading cause of childhood mortality [6]. Thus, the National
PMTCT Programme added an early infant diagnosis (EID)
program using HIV deoxyribonucleic acid (DNA) polymerase
chain reaction (PCR) testing to the package of comprehensive
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PMTCT services in 2007 [7]. The Ministry of Health and Child
Care (MOHCC) in Zimbabwe, in an effort to reduce MTCT of
HIV from an estimated 30% in 2009 to ,5% by 2015 [8],
adopted the 2010 WHO/PMTCT Option A recommendations.
For pregnant women with CD4 #350, antiretroviral therapy
(ART) is provided for life, and for pregnant women with CD4 .
350 zidovudine is provided during pregnancy and single-dose
nevirapine (sdNVP) at delivery, followed by daily nevirapine
(NVP) syrup for infants throughout the duration of breastfeeding.
The WHO and UNAIDS has identified that decentralizing and
integrating HIV care and treatment services with other areas of
health care, such as maternal and child health services as a key
strategy for maximizing access to these services [9]. In Lusaka,
Zambia, integration of ART into existing public sector maternal
and child health clinics doubled the proportion of women
initiating ART [10]. It has been shown that integration of HIV
services with other clinic-based services such as antenatal care,
nutritional services, and family planning positively affects uptake of
ART [10,11], and reduces time to treatment initiation [12].
Rollins et al. showed that EID integration can be effective when
combined with immunization clinics [13]. A recent Cochrane
review concluded that integration is feasible and is promising in
improving health and behavioural outcomes toward HIV treat-
ment and care; however, gaps remain in research to determine
effectiveness of integration [14].
We conducted a rapid assessment to review the integration
between PMTCT services providing to HIV-exposed infants,
including EID programs, and HIV care and treatment for HIV-
infected mothers and children during postpartum period in the
primary MCH facilities in Zimbabwe
Methods
Study design
Between August and December 2012, we conducted a cross-
sectional survey of a nationally representative sample of public
MCH facilities providing routine MCH care services. Using a
structured questionnaire, data were collected from 151 facilities
through phone interviews; self-administrative questionnaires sent
through mail, email or delivered in person.
Sampling frame
Facilities surveyed included primary health care facilities,
district hospitals, mission/rural hospitals, and provincial hospitals.
Primary health care facilities provide basic outpatient services at
the entry level of care. District/mission hospitals are comprised of
government designated hospitals in districts without a government
hospital, where in addition to primary care, emergency services
are provided. Provincial hospitals constitute the highest referral
level in the province including specialists in different medical
disciplines [6]. Of 1,542 public MCH facilities, we selected 1,007
facilities providing $100 of the 1st diphtheria-pertussis-tetanus
(DPT1) vaccinations to infants in 2011 in Zimbabwe. Facilities
providing ,100 DPT1 vaccinations (representing 8.6% (n = 535)
of the total infants receiving the 1st DPT in 2011) were excluded
due to resource and logistical considerations. Using quartile
distribution of the number of DPT1 vaccinations providing by the
eligible facilities in 2011, the 1007 eligible facilities were originally
grouped into four groups, facilities providing 100–140 the 1st
DPT, 141–235, 236–329, and $330 the 1st DPT vaccinations.
Since services providing at facilities in the 2nd and 3rd quartile were
similar, we combined these two groups into one group. To ensure
the representation of participating facilities from each stratum
including the combined group of the 2nd and the 3rd quartile, we
randomly selected 15% of eligible facilities from each stratum;
thus, a total of 151 facilities from all 10 provinces in Zimbabwe
were included in our final facility sample.
Data collection tools
The standardized paper questionnaire (English version), which
was piloted in five different facilities, was mailed to the head nurse
at each selected facility with a request to return it within two
weeks. For those sites that did not complete the questionnaire
within 2 weeks, a data collector interviewed the clinic nurse over
the phone with the same questionnaire. If a site was unreachable
by mail, then by phone after four attempts, the interview was
conducted at the site. On average the questionnaire took 15–
20 minutes to complete.
The questionnaire instrument surveyed each selected facility
about human resources, staff training needs for conducting HIV
testing in children ,2 years of age, infant DBS sample
transportation from facility to the national laboratory, turnaround
time of test results to facility, PMTCT services, postnatal care, and
HIV care and treatment linkages for HIV-infected mothers and
children and HIV-exposed infants in 2012. Additionally, NMRL
was asked to provide information whether DBS were ever
submitted from the selected facilities.
Data analysis
We defined a clinic providing (1) a basic postnatal PMTCT
package if at least the following services were provided: DBS
sample collection and nevirapine and cotrimoxazole prophylaxis
for HIV-exposed infants; and (2) a comprehensive PMTCT and
HIV care and treatment package if the following were provided at
the same facility: HIV testing and counselling for adults, CD4
count testing on site, and adult and pediatric HIV care and
treatment (ART) in addition to the basic postnatal PMTCT
package. We defined integration of EID with routine MCH
services as the facility offering DBS collection along with
immunizations or postnatal visit care.
Since NMRL was the only laboratory where DBS samples are
processed for EID and is located in Harare, we estimated distance
the DBS samples and results would need to travel to get to NMRL
as a potential factor associated with EID test result’s turnaround
time (TAT). We grouped those facilities located in provinces that
border Harare (Mashonaland East, Mashonaland Central, Ma-
shonaland West) as the ‘‘close to NMRL’’ group; and the other
facilities were in the ‘‘far from NMRL’’ group.
Turnaround time (TAT), an important determining factor for
efficiency of the national EID program, was defined as the time
from the day the DBS sample was collected to the day that HIV
DNA PCR results are returned to the facility. Methods of
transport were also analysed for potential associated factors with
TAT for DBS results. We grouped MOHCC, the City Health
Department, and ambulance into a group called ‘‘internal
transport’’ and other public transport and courier transport into
‘‘public methods.’’
Descriptive and logistic regression analysis methods were used.
Data were analysed using SAS Enterprise Guide software version
4.3 (SAS Institute Inc. 2011. Base SAS 9.3 Procedures Guide.
Cary, NC: SAS Institute Inc.).
The assessment was approved as part of the evaluation of the
effectiveness of the national PMTCT program in Zimbabwe
(ZWPMTCTE) by the institutional review board of the Zimbabwe
Medical Research Council and the Office of Associate Director of
Science at the United States Centers for Disease Control and
Prevention (CDC). Since the assessment did not obtain sensitive
information or personal opinions, clinic nurses provided verbal
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consent to participate in the assessment. Of those who refused to
participate in the assessment, we documented in the database as
‘‘Not complete’’ and their clinics were still eligible to participate in
the evaluation of ZWPMTCTE.
Results
Out of the 151 selected facilities, 139 (92%) completed the
survey with 55 by mail, 79 over the phone, and five in person; 12
(8%) facilities did not complete the survey (Figure 1). Most of the
non-response facilities were in medium- and high-patient volume
facilities (Figure 1). Table 1 shows that 85% (n = 118) of the
responding selected facilities were primary health care facilities,
5% were district hospitals, 9% were mission or rural hospitals and
1% were provincial hospitals.
PMTCT, EID, and antiretroviral therapy (ART) services for
adults and children
Of 139 responding facilities, 100% reported having at least one
staff member trained in collecting DBS samples for HIV DNA
testing (Table 1), and 98% (n = 136) reported providing postnatal
care services. Although DBS collection scheduled at 6 weeks
postpartum was reportedly provided in 99% (n = 138) of the
facilities, the NMRL report indicated that DBS was submitted
from all selected facilities in 2012. The DBS collection service was
reported offering in conjunction with the 1st DPT immunisations
at 83% (n = 114), and with postnatal visits at 80% (n = 111) of the
responding facilities.
HIV testing and counselling for adults including men and
women also were reported to be provided at most (90%) of
responding facilities. On-site CD4 testing (using a point-of-care
machine) was offered to HIV-infected patients in 21% of low-
volume facilities, 38% of medium-, and 46% of high-volume
facilities. There were no detectable differences between the three
strata in any other category of service provision. Pediatric and
adult HIV treatment were also not universal; however, more
facilities offered adult HIV treatment (65%) than pediatric HIV
treatment (58%) (p = 0.012).
Although providing a basic postnatal PMTCT service package
including EID, extended nevirapine prophylaxis during the
breastfeeding period, and cotrimoxazole to HIV-exposed infants,
was reported in 99% of the responding facilities, the comprehen-
sive package for postnatal PMTCT including HIV care and
treatment services (ART) for adults and children was provided at
only 27% (n = 37) of the facilities (Table 1). CD4 testing or HIV
treatment for children or adults necessitated referral in 73%
(n = 121) of facilities. However, at the referral facilities HIV care
and treatment services were usually available to both adults and
children at the same facility except in one case. That single case
was in a city where the referral clinics were not far from each
other.
A percentage of facilities reported needing to refer for the
following services: 10% (14) for HIV testing and counselling, 63%
(87) for CD4 testing, 42% (57) for pediatric care and treatment,
35% (47) for adult HIV care and treatment. Estimated distance to
referral site from primary facility site is described in table 2. The
median distance that referred patients may have to travel to reach
HIV testing and counselling is 33 km (range, 1.5–60 km), to reach
pediatric and adult care and treatment services was 17 km (range,
1.5–140 km), and to reach CD4 testing facilities was 24.5 km
(range, 0.5–140 km).
Figure 1. Sampling of Facilities and Response Rate by Stratum. DPT: The 1st diphtheria-pertussis-tetanus vaccination.
doi:10.1371/journal.pone.0098236.g001
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EID (DBS) test result turnaround time
Only 19% of facilities reported a TAT of less than 4 weeks,
although 71% sent DBS samples weekly to the NMRL for DNA
PCR testing. The collected DBS samples were sent to the NMRL
either directly (15%), through intermediaries at the provincial level
(13%), or through intermediaries at the district level and then
provincial levels (72%). The NMRL generally sent the test results
to facilities using the same route in which the DBS were sent to
them.
Bivariate analysis (Table 3) suggests that methods of transport-
ing DBS samples to NMRL have no association with TAT (p.
0.05). We also found that how DBS samples get sent to the
laboratory (directly vs. through intermediary), frequency of
sending DBS samples, proximity of province to NMRL, patient
volume, and number of transport methods utilized were not
associated with TAT in bivariate analysis. Only when stratified by
closeness to the laboratory, utilizing MOHCC (p,0.05) and
environmental health technicians (EHT) (p,0.0005) were associ-
ated with shorter TAT in the facilities in provinces closer to the
NMRL (not included Table 3).
None of the factors proved to be statistically significant
associated with TAT in a logistic regression model that included
distance from province to NMRL, frequency of sending DBS,
where DBS get sent, number of transport methods utilized, using
Table 1. Service provision model in integrating EID, PMTCT, HIV/AIDS care and treatment into MCH setting during post-delivery
period in Zimbabwe, 2012 (N = 139).




Primary health care 118 of 139 (85%)
District Hospital 7 of 139 (5%)
Mission/Rural Hospital 13 of 139 (9%)
Provincial hospital 1 of 139 (1%)
Staff
Training on EID 139 of 139 (100%)
Training and provide EID 138 of 139 (99%)
Service provisiond
DBS collection 138 of 139 (99%) 36 of 36(100%) 67 of 68 (98%) 35 of 35(100%)
HIV testing and counselling for mothers 123 of 137 (90%) 33 of 35 (94%) 57 of 67 (85%) 33 of 35 (94%)
POC CD4 testing machine on site 49 of 136 (36%) 7 of 33 (21%) 26 of 68 (38%) 16 of 35 (46%)
Adult HIV Treatment 88 of 135 (65%) 18 of 32 (56%) 38 of 68 (56%) 22 of 35 (63%)
Pediatric HIV Treatment 78 of 135 (58%) 22 of 33 (67%) 39 of 67 (58%) 27 of 35 (77%)
Infant-DBS collection for HIV testing (EID)
Provision at the same time with infant’s immunizations
(integrated)
114 of 138 (83%)
Package of comprehensive PMTCT and maternal and
child HIV care and treatment services(1)
37 of 138 (27%)
(1)including HIV testing and counselling, DBS collection, nevirapine and cotrimoxazole prophylaxis, CD4 point of care machine on site, and Adult and pediatric HIV
treatment.
dVarying total N (denominator) due to missing data.
*percentages add to greater than 100% because facilities provide more than one type of service.
¤Facilities with 100–140 yearly DPT visits (low stratum).
tFacilities with 141–329 yearly DPT visits (medium stratum).
¥Facilities with 330+ yearly DPT visits (high stratum).
doi:10.1371/journal.pone.0098236.t001
Table 2. Referral services needed and distance from the primary facilities (N = 121).
Service referred (N = 121) Number of facilities
Median distance to referral,
range [standard deviation]
N (%) with Distance between the primary facility to Referral Site
(km)
0–10 10–20 .20
HIV testing and counselling for
adult
14 33 km (1.5–60 km) [10.8] 3 (21.4%) 3 (21.4%) 8 (57.2%)
CD4 testing 66 24.5 km (0.5–140 km) [25.8] 19 (28.8%) 11 (16.7%) 36 (54.5%)
Pediatric HIV Treatment 43 17 km (1.5–140 km) [22.4] 18 (41.9%) 9 (20.9%) 16 (37.2%)
Adult HIV Treatment 33 17 km (1.5–140 km) [22.0] 13 (39.4%) 5 (15.2%) 15 (45.5%)
doi:10.1371/journal.pone.0098236.t002
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MOHCC transport for DBS or results, and using EHT for
transport of DBS or results.
Discussion
The results of this first assessment using a national representa-
tive sample of public facilities in Zimbabwe. The assessment
provides an overall picture of success of implementing a national-
scale EID programme, integrating PMTCT services, and deliver-
ing HIV care and treatment for mothers and infants during post-
delivery within the public MCH setting in Zimbabwe as of
December 2012. Furthermore, our findings provide identified gaps
that need to be addressed in order to successfully scale-up the
national ART as well as roll-out the national PMTCT option B+
which started in January 2014.
It is encouraging that 100% of sampled facilities had staff
trained in collecting DBS from infants for HIV testing and that
DBS sample collection was offered at 99% of sampled facilities in
2012, which surpasses the MOHCC goal of 95% by 2015 [6]. In
addition, our findings show that basic PMTCT services for HIV-
exposed infants were provided at almost all facilities (99%).
Furthermore, EID is integrated with other routine services at the
same location which were offered to infants such as immunizations
and postnatal visits in the majority of facilities, 82% and 80%,
respectively. This integration will potentially provide opportunities
to reduce loss to follow-up [15], allowing early initiation of
treatment for HIV-infected infants as well as further preventing
MTCT during breastfeeding, which may reduce infant mortality
from HIV [16]. However, only 58% of facilities offered ART for
HIV-infected children and adults including mothers, with referral
facilities located, on average, 17 km (range, 1.4 to 140 km) away
from the primary facility. For women with no transport options
this may be an insurmountable challenge, contributing to loss to
follow-up secondary to poor linkages in the system. Although
Zimbabwe has adopted the 2013 WHO PMTCT recommenda-
tions in which all HIV-positive pregnant women will be on ART
for life (Option B+) since January 2014, knowing a mother’s CD4
count may not be urgently but is needed to monitor treatment.
With less than 41% and 21% of clinics at medium/high and low
patient volume facilities, respectively, providing CD4 testing with a
point-of-care machine on site, potential for monitoring ART
treatment may be negatively affected. The median distance
travelled for CD4 testing if not provided at the site is 24.5 km,
and this distance to receive testing could impact determining of
switching ART regimens in a timely fashion.
Table 3. Bivariable analysis: Factors associated to turnaround time for DBS HIV DNA PCR testing.
Characteristic N % with Turnaround time ,4 weeks P value*





Transport DBS/results with public methods (public transport, courier) 0.526
Yes 79 19
No 56 18
Transport DBS/results with Environmental Health Technicians 0.097
Yes 23 30
No 112 16
Where the DBS get sent
No intermediate stops–Send directly to the National Microbiology Reference
Laboratory (NMRL)
21 24 0.341
One intermediate stop—sending to provincial hospital 17 18 0.650
Two intermediate stops—sending to district hospital 98 18 0.634
Frequency of sending DBS 0.420
At least weekly 96 20
Less frequent than weekly 37 16
Facility in province close to the NMRL 0.775
Yes 55 16
No 80 20
Facility volume stratum 0.709
Low (100–140 yearly DPT visits) 35 23
Medium (141–329 yearly DPT visits) 67 18
High (330+ yearly DPT visits) 33 15




*Using Fisher’s exact test one sided.
doi:10.1371/journal.pone.0098236.t003
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With only 65% of facilities provide ART to all adults including
pregnant and breastfeeding women by 2012, Zimbabwe will face
challenges in rolling out the PMTCT option B+ and reaching the
national goal of increasing infant ART provision coverage to 90%
of all facilities by 2015. The lack of ART integration with services
in the MCH setting for both mother and infant may increase the
risk of infant/maternal mortality due to loss to follow-up for those
who need treatment [15].
Turnaround time of the HIV DNA test results using infant-DBS
as part of the EID services was found to be longer than the
recommended 4 weeks at 81% of facilities, and in many cases was
.2 months. Since we could not find any factors that were
statistically significant associated with TAT, we suspect that one
main delay of the TAT could be lack of capacity at NMRL, the
only public laboratory that could perform HIV DNA PCR in
Zimbabwe at the time of the survey. Ongoing efforts to expand the
NMRL to one or two more regional/satellite laboratories may
help improve the TAT. The delay in receiving results is one
contributor to decreased rates of early initiation of treatment for
HIV-infected infants to higher infant mortality [17]. Promptness
of infant HIV testing and linkage to prophylaxis and treatment
initiation are essential; it was shown by Violari et al. (2008) that
EID and early initiation of ART therapy at a median age of seven
weeks significantly reduces infant mortality and progression of
HIV compared to delayed initiation [16]. EID and HIV service
uptake may be improved when the complete package of essential
services for quality maternal care, including HIV testing and
counselling, treatment, and care services, are easy to access and
are integrated into existing clinic functions [14,18,19]. The
improved integration of EID with combined HIV service packages
as well as routine clinic services could potentially increase ART
uptake and decrease maternal mortality from HIV, in turn
reducing the likelihood that infants become AIDS orphans.
This rapid assessment has some limitations. Our findings may
not be representative for small facilities providing ,100 DPT1
immunizations annually since we excluded them from our
sampling frame. Although our response rate was relatively high
(93%) and sampling frame was capturing a national representative
sample of public MCH facilities in Zimbabwe, our sample size of
139 facilities may be moderately small to measure some specific
outcomes of the integrations. Our findings were also mostly based
on self-report which could have led to recall bias and social
desirability bias in the interview methods. The different methods
used to administer the survey, including self-administration and
interviewer-administration might have influenced reporting de-
pending on the method utilized. Although our findings provide
critical descriptive baseline information on integrations between
PMTCT and HIV care and treatment programs just before the
PMTCT option B+ was rolling out, future studies should directly
measure outcomes of these integrations such as coverage of the 6-
week EID, retention rates in care and treatment, as well as
maternal and child survival.
Zimbabwe has successfully scaled and integrated the national
EID and PMTCT programs into the existing MCH primary
health care setting among facilities that provide $100 DPT1
vaccinations to infants. However, the long TAT of EID (DBS) test
results, and the lack of decentralized and integrated ART
programs in the MCH primary health care setting could reduce
the effectiveness of the national PMTCT as well as ART
programs. Addressing these important gaps will support continual
improvement of the EID system, and ensure the success of
adopting the 2013 WHO PMTCT recommendations started in
January 2014 in which HIV-infected pregnant and breastfeeding
women will receive ART in Zimbabwe. Addressing the important
gaps identified in this assessment will be necessary to reach the
elimination MTCT goals and keeping mothers and babies alive in
Zimbabwe.
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